EC Number | Protein Variants | Comment | Organism |
---|---|---|---|
2.3.1.21 | S113L | natural missense mutation of CPT II, enzyme deficiency leads to myopathic syndroms, metabolic characterization, e.g. insulin resistance, increased content of muscle lipidsreduced lipolysis | Homo sapiens |
EC Number | Natural Substrates | Organism | Comment (Nat. Sub.) | Natural Products | Comment (Nat. Pro.) | Rev. | Reac. |
---|---|---|---|---|---|---|---|
2.3.1.21 | acyl-CoA + L-carnitine | Homo sapiens | enzyme has a key function in regulation of fatty acid beta-oxidation | CoA + L-acylcarnitine | - |
? |
EC Number | Organism | UniProt | Comment | Textmining |
---|---|---|---|---|
2.3.1.21 | Homo sapiens | - |
CPT II deficient mutant | - |
EC Number | Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|---|
2.3.1.21 | acyl-CoA + L-carnitine | - |
Homo sapiens | CoA + L-acylcarnitine | - |
? | |
2.3.1.21 | acyl-CoA + L-carnitine | enzyme has a key function in regulation of fatty acid beta-oxidation | Homo sapiens | CoA + L-acylcarnitine | - |
? |